Company Filing History:
Years Active: 2022-2025
Title: Marie Mandron: Innovator in Chikungunya Virus Therapeutics
Introduction
Marie Mandron is a prominent inventor based in Paris, France. She has made significant contributions to the field of virology, particularly in the development of therapeutics for Chikungunya virus (CHIKV). With two patents to her name, her work is paving the way for innovative treatments that could benefit many.
Latest Patents
Marie Mandron's latest patents focus on the development of anti-CHIKV antibodies and their therapeutic uses. The first patent concerns antibodies and antigen-binding fragments that specifically bind to and neutralize the Chikungunya virus. These engineered antibodies aim to develop therapeutics for treating CHIKV disease or preventing CHIKV infection. The second patent also addresses anti-CHIKV monoclonal antibodies directed against the E2 structural protein, further emphasizing the potential for pharmaceutical compositions that utilize these antibodies for prevention and treatment.
Career Highlights
Marie Mandron is currently associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to focus on innovative solutions to combat viral infections, particularly those caused by CHIKV. Her dedication to research and development in this area has positioned her as a key figure in the fight against emerging viral diseases.
Collaborations
Marie collaborates with talented individuals such as Kara Carter and Cendrine Lemoine. These partnerships enhance her research efforts and contribute to the advancement of therapeutic options for CHIKV.
Conclusion
Marie Mandron's innovative work in developing anti-CHIKV antibodies represents a significant advancement in the field of virology. Her contributions are crucial for the development of effective treatments for Chikungunya virus, showcasing her commitment to improving public health.